RESEARCH

Ovarian Cancer

WebsiteImageOvCa-CooperSJCan genomic profiles predict drug response?

The genomics of drug response in ovarian cancer

In collaboration with clinicians and scientists at UAB, the Sara Cooper Lab has begun to explore whether genomic profiling can help predict patient drug response. We are using gene expression profiling to identify new drugs that may be used to treat ovarian cancer and also to determine whether gene expression patterns in tumors and peripheral fluids of patients might be useful for predicting response to current standard treatments.

Navigation

Color Skin